Credit Suisse’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-11,282
Closed -$208K 4340
2017
Q3
$208K Buy
+11,282
New +$195K ﹤0.01% 3916
2015
Q4
Sell
-11,656
Closed -$210K 4464
2015
Q3
$210K Buy
+11,656
New +$260K ﹤0.01% 3906

Other funds holding ENTL

Credit Suisse's ENTL Position: Q4 2017 in Review

Credit Suisse sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q4 2017, closing a stake of 11,282 shares — an estimated $208K sold.

Credit Suisse first reported a position in ENTL in Q3 2015 and held it in 2 quarters. The position peaked at $210K in Q3 2015. 83 funds tracked by Wall St. Rank hold ENTL as of Q4 2017.

  • Credit Suisse reported no remaining Entellus Medical, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Credit Suisse sold 11,282 Entellus Medical, Inc. Common Stock shares in Q4 2017, an estimated $208K.
  • Credit Suisse first reported a position in Entellus Medical, Inc. Common Stock in Q3 2015 and held it in 2 quarters.
  • Credit Suisse's Entellus Medical, Inc. Common Stock position peaked at $210K in Q3 2015.
  • 83 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q4 2017.

Based on Credit Suisse's 13F filing for Q4 2017, filed 14 Feb 2018.